Salix Pharmaceuticals.

PositionTriangle - Initial public offering - Brief Article

RALEIGH -- Salix Pharmaceuticals went public in March, selling 4 million shares of common stock at $13.37 each. The drug company plans to use the expected proceeds of $50 million to develop its first two drugs, Lumenax, for traveler's...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT